NCT05096338 2025-03-18
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
Clinical Trials
5 trialsNCT04659343 2025-03-05
TDM for Optimized Outcome in Patients With mRCC.
University of Aarhus
Recruiting
NCT05899751 2024-05-10
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Unknown
NCT02324803 2014-12-24
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Southern China Urology Cancer Consortium
Phase 2 Unknown
NCT00006105 2013-09-05
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
University of Chicago
Phase 2 Completed